How I Adapt CLL Treatment to Evolving Molecular Considerations

Discussion - How should factors such as del(17q) andIgHV mutations be leveraged to individualize treatment in CLL?
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research
More News: Hematology | Leukemia